Abbott Laboratories (ABT)

Abbott Laboratories Stock Forecast

Stock Price Forecast

According to 19 professional analysts, the 12-month price target for Abbott Laboratories stock ranges from a low of $120 to a high of $159. The average analyst price target of $143.68 forecasts a 7.59% increase in the stock price over the next year.

Price Target: $143.68 (+7.59%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$120	$143.68	$145	$159
Change	-10.15%	+7.59%	+8.57%	+19.06%

* Price targets were last updated on Jul 18, 2025.

Analyst Ratings

The average analyst rating for Abbott Laboratories stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Apr '25	May '25	Jun '25	Jul '25	Aug '25	Sep '25
Strong Buy	7	7	7	9	9	8
Buy	8	8	8	8	8	8
Hold	4	4	4	3	3	3
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	19	19	19	20	20	19

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Joanne Wuensch Citigroup	Citigroup	Strong Buy Maintains $157 → $155	Strong Buy	Maintains	$157 → $155	+16.06%	Jul 18, 2025
Lawrence Biegelsen Wells Fargo	Wells Fargo	Buy Maintains $147 → $142	Buy	Maintains	$147 → $142	+6.33%	Jul 18, 2025
Jayson Bedford Raymond James	Raymond James	Buy Maintains $142 → $141	Buy	Maintains	$142 → $141	+5.58%	Jul 18, 2025
Anthony Petrone Mizuho	Mizuho	Hold Maintains $140 → $135	Hold	Maintains	$140 → $135	+1.09%	Jul 18, 2025
Matthew Taylor Jefferies	Jefferies	Hold → Strong Buy Upgrades $143 → $145	Hold → Strong Buy	Upgrades	$143 → $145	+8.57%	Jul 18, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

45.14B

Increased by 7.61%

from 41.95B

Revenue Next Year

48.68B

Increased by 7.84%

from 45.14B

EPS This Year

5.20

Decreased by -31.98%

from 7.64

EPS Next Year

5.73

Increased by 10.22%

from 5.20

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	34.61B	43.08B	43.65B	40.11B	41.95B	45.14B	48.68B
Revenue Growth	8.48%	24.47%	1.34%	-8.12%	4.59%	7.61%	7.84%
EPS	2.50	3.94	3.91	3.26	7.64	5.20	5.73
EPS Growth	21.53%	57.38%	-0.76%	-16.62%	134.36%	-31.98%	10.22%
Forward PE	-	-	-	-	-	25.70	23.32
No. Analysts	-	-	-	-	-	32	32

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027	2028	2029
High	47.2B	51.3B
Avg	45.1B	48.7B
Low	43.5B	46.2B

Revenue Growth

Revenue Growth	2025	2026	2027	2028	2029
High	12.6%	13.6%
Avg	7.6%	7.8%
Low	3.7%	2.2%

EPS Forecast

EPS	2025	2026	2027	2028	2029
High	5.43	6.06
Avg	5.20	5.73
Low	5.01	5.45

EPS Growth

EPS Growth	2025	2026	2027	2028	2029
High	-28.9%	16.6%
Avg	-32.0%	10.2%
Low	-34.5%	4.9%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.